natriuretic

(redirected from Natriuretic peptides)
Also found in: Dictionary, Medical.

natriuretic

[¦nā·trē·yu̇′red·ik]
(pharmacology)
A medicinal agent which inhibits reabsorption of cations, particularly sodium, from urine.
References in periodicals archive ?
USA], August 26 ( ANI ): Recent research shows that elevated levels of natriuretic peptides in adipose tissue protect against effects of high-fat diet.
All natriuretic peptides in humans contain a preserved ring structure of 17 amino acid residues and form an intramolecular disulfide bond, which presumably is responsible for receptor binding.
Suzukia, Yamazaki T, Yazaki Y The role of the natriuretic peptides in the cardiovascular system.
Objective: To investigate the role of N-terminal pro-brain natriuretic peptide and apelin in the assessment of right ventricular dysfunction in acute pulmonary embolism.
The limitation of the present study was, the patients were receiving diuretics, beta-blockers, ACE inhibitors spironolactone therapy, with different dosages and we did not take the medication and obesity into account, some patients have low levels of NT-pro BNP, the suggested explanation could be that they respond to the optimal therapy; another explanation is that patients with end stage HF may have low natriuretic peptides (NP) levels because the ability of their ventricles to release NP may have become exhausted.
Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants.
Preclinical and clinical data have shown that the natriuretic peptide class can act on multiple disease processes that play a role in the negative outcomes associated with heart failure.
Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.
B-type (or brain) natriuretic peptide (BNP) is a member of a family of peptides, the natriuretic peptides that increase urinary excretion of sodium (natriuresis) and water (diuresis) and stimulate vasodilatation (10,11).
PL-3994 has an extended half-life, with reduced affinity for natriuretic peptide clearance receptors and increased resistance to neutral endopeptidase, an endogenous enzyme that degrades natriuretic peptides.